select trial semaglutide SELECT: Semaglutide's Impact on CVD Events Emerges Quickly SELECT Trial
Description
This product is not intended for human consumption, personal use, or therapeutic application of any kind


The Appetite Revolution Theres a slightly awkward conversation happening in the health world right now

The mean weight loss among patients prescribed GLP-1 analogue monotherapy at 12 months was 11.42kg, SD 9.95 (9.6% TBWL)

Learn the science